Glaukos Corp. (NYSE: GKOS) reversed year ago losses of 40 cents per share to post a greater than expected profit for the first quarter of 3 cents per share and forecast full year revenue ahead of estimates. Shares of the opthalmic medical technology company leaped $4.40 to $24.28.
